Literature DB >> 18280621

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3.

Tatiana Gartner1, Marta Romano, Vanessa Suin, Michaël Kalai, Hannelie Korf, Patrick De Baetselier, Kris Huygen.   

Abstract

DNA vaccination is a potent means for inducing strong cell-mediated immune responses and protective immunity against viral, bacterial and parasite pathogens in rodents. In an attempt to increase cross-presentation through apoptosis, the DNA-encoding caspase-2 prodomain followed by wild-type or catalytically inactive mutated caspase-3 was inserted into a plasmid encoding the 32 kDa mycolyl transferase (Ag85A) from Mycobacterium tuberculosis. Transient transfection showed that the mutated caspase induced slow apoptosis, normal protein expression and NF-kappaB activation while wild-type caspase induced rapid apoptosis, lower protein expression and no NF-kappaB activation. Ag85A specific antibody production was increased by co-expressing the mutated and decreased by co-expressing the wild-type caspase. Vaccination with pro-apoptotic plasmids triggered more Ag85A specific IFN-gamma producing spleen cells, and more efficient IL-2 and IFN-gamma producing memory cells in spleen and lungs after M. tuberculosis challenge. Compared to DNA-encoding secreted Ag85A, vaccination with DNA co-expressing wild-type caspase increased protection after infection with M. tuberculosis, while vaccination with plasmid co-expressing mutated caspase was not protective, possibly due to the stimulation of IL-6, IL-10 and IL-17A production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280621     DOI: 10.1016/j.vaccine.2007.12.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Use of Staby(®) technology for development and production of DNA vaccines free of antibiotic resistance gene.

Authors:  Anca Reschner; Sophie Scohy; Gaëlle Vandermeulen; Marc Daukandt; Céline Jacques; Benjamin Michel; Hans Nauwynck; Florence Xhonneux; Véronique Préat; Alain Vanderplasschen; Cédric Szpirer
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

2.  Induction of ER stress in macrophages of tuberculosis granulomas.

Authors:  Tracie A Seimon; Mi-Jeong Kim; Antje Blumenthal; Jovanka Koo; Sabine Ehrt; Helen Wainwright; Linda-Gail Bekker; Gilla Kaplan; Carl Nathan; Ira Tabas; David G Russell
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

3.  Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis.

Authors:  Joseba M Garrido; Iker A Sevilla; Beatriz Beltrán-Beck; Esmeralda Minguijón; Cristina Ballesteros; Ruth C Galindo; Mariana Boadella; Konstantin P Lyashchenko; Beatriz Romero; Maria Victoria Geijo; Francisco Ruiz-Fons; Alicia Aranaz; Ramón A Juste; Joaquín Vicente; José de la Fuente; Christian Gortázar
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

4.  Trafficking and processing of bacterial proteins by mammalian cells: Insights from chondroitinase ABC.

Authors:  Elizabeth Muir; Mansoor Raza; Clare Ellis; Emily Burnside; Fiona Love; Simon Heller; Matthew Elliot; Esther Daniell; Debayan Dasgupta; Nuno Alves; Priscilla Day; James Fawcett; Roger Keynes
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

Review 5.  Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.

Authors:  Kai Ling Chin; Fadhilah Zulkipli Anis; Maria E Sarmiento; Mohd Nor Norazmi; Armando Acosta
Journal:  J Immunol Res       Date:  2017-06-20       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.